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ABSTRACT
Objective: We compared the automated non-
treponemal reagin (rapid plasma reagin (RPR)) test
with the conventional RPR card test for usefulness in
clinical applications.
Setting: A comparative study of laboratory methods
using clinical specimens in a single institute.
Participants: A total of 112 serum samples including 59
Treponema pallidum particle agglutination (TPPA)-positive
and 53 TPPA-negative specimens were evaluated.
Outcome measures: HiSens Auto RPR LTIA (HBI,
Anyang, Korea) was compared with Macro-Vue RPR Card
Tests (Becton Dickinson BD Microbiology Systems,
Sparks, Maryland, USA). Treponemal-specific tests were
performed by Serodia TPPA assay (Fujirebio, Tokyo,
Japan). The percentage agreement, κ value and overall
sensitivity and specificity of the two RPR tests were
compared. Seroconversion rates after treatment were also
compared for each RPR test.
Results: The percentage agreement between the two RPR
tests was 78.6% (κ 0.565; 95% CI 0.422 to 0.709).
Sensitivity and specificity of the automated RPR test
relative to the TPPA test was 52.5% (95% CI 39.1% to
65.7%) and 94.3% (95% CI 84.3% to 98.8%),
respectively, while the same values for the conventional
RPR card test were 86.4% (95% CI 75% to 93.9%) and
94.3% (95% CI 84.3% to 98.8%), respectively. The
conventional RPR card test showed overall higher
positivity than the automated RPR test, whereas the
automated RPR test showed higher seroconversion
(43.5%, 10/23) than the conventional RPR card test
(4.3%, 1/23) in treated patients.
Conclusions: The automated RPR test showed overall
lower sensitivity than the conventional RPR test based on
the treponemal test, but higher seroconversion after
treatment. The automated RPR test could be used to
monitor treatment response, especially in the reverse
screening algorithm in syphilis testing.
INTRODUCTION
There has been a rapid decrease in positive
rates for syphilis since the 1970s in Korea,
consistent with the global trend. In 2000,
∼0.2% of the general Korean population was
estimated to be syphilis-positive; since that
time, levels appear to have decreased, and
the prevalence rate is still very low.1 Despite
these low rates, syphilis is an important infec-
tion because it can cause serious health pro-
blems including neurosyphilis and
congenital infection. Appropriate screening,
conﬁrmation and follow-up protocols are
required.2–4 Serological analysis of non-
treponemal reagin tests, such as the Venereal
Disease Research Laboratory (VDRL), rapid
plasma reagin (RPR) and treponemal tests
such as the Treponema pallidum haemagglutin-
ation assay (TPHA), the Treponema pallidum
particle agglutination (TPPA) test, the ﬂuor-
escent treponemal antibody absorption test,
and the Treponema-speciﬁc antibody test, have
been used to diagnose and monitor syphilis
infections. Recently, there have been issues
regarding selection of the best algorithm for
initial screening and follow-up by either
Strengths and limitations of this study
▪ Automated rapid plasma reagin (RPR) testing
has been introduced in clinical laboratories, so
we compared the automated test with the con-
ventional RPR card tests.
▪ The automated RPR test showed overall lower
positivity than the conventional RPR test com-
pared with the treponemal test, Treponema palli-
dum particle agglutination (TPPA).
▪ The automated RPR test showed higher serocon-
version after treatment than the conventional
manual RPR test. So, the automated RPR test
could be used to monitor treatment response,
especially in the reverse screening algorithm for
syphilis testing.
▪ Limitations of this study are small sample size
and the patient groups could not be accurately
categorised according to the stage of the disease
because of the low prevalence of syphilis in
Korea.
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non-treponemal- or treponemal-speciﬁc tests.2 5 6 The
Centers for Disease Control and Prevention (CDC) still
recommend that a non-treponemal reagin test is used as
the ﬁrst-line diagnostic approach.2 Two kinds of non-
treponemal test have been widely used: VDRL and RPR.
RPR is the most common ﬁrst-line non-treponemal test
used to screen for syphilis infection.7 Recently, auto-
mated RPR tests have been introduced, but variable
results were reported when the automated test was com-
pared with conventional RPR card tests.8 The automated
RPR test has some advantages over the conventional
RPR card test, such as greater capacity to deal with a
large number of samples, minimal person-to-person vari-
ation, and simple automated procedures.
The aim of this study was to evaluate the possible ben-
eﬁts of an automated RPR test compared with a conven-
tional RPR card test in clinical application.
METHODS
Subjects
All sera testing positive for syphilis by one or more tests
from November 2012 to April 2013 from a university
hospital were included, along with matched controls.
Remnant sera from requested treponemal tests after con-
ﬁrmation were included and preserved at −70°C until
analysis. Patients were not categorised according to syph-
ilis stage because of the infrequency of syphilis infection.
Cases of true syphilis were very rare because of the low
prevalence of syphilis in this country. The aim of this
study was to evaluate the same RPR tests with ethically
protected remnant specimens. This case was exempted
by the institutional review board. All study processes
complied with the World Medical Association
Declaration of Helsinki.
The automated RPR test was compared with the manual
RPR card test (Becton Dickinson BD Microbiology Systems,
Sparks, Maryland, USA). A conﬁrmatory treponemal-
speciﬁc test was performed using a TPPA assay according to
the manufacturer’s instructions. Seroconversion rates of
each non-treponemal RPR test were evaluated on 23 syphil-
itic patients with a medical history of syphilis treatment.
Serological tests
Conventional RPR card test
The Macro-Vue RPR Card Test (Becton Dickinson BD
Microbiology Systems) uses cardiolipin antigen with a
carbon particle to detect reagin. Reagin binds to the test
antigen, which consists of cardiolipin–lecithin–cholesterol
particles, causing macroscopic ﬂocculation. Controls were
established for each test to conﬁrm optimal reactivity of
the antigen. The test procedure was followed according to
the manufacturer’s instructions.
Automated RPR test
HiSens Auto RPR LTIA (HBI, Anyang, Korea) is a latex
turbidimetric immunoassay using latex particles coated
with lecithin and cardiolipin. The latex particles react
with the reagin in the serum of patients with syphilis.
The 15 μL serum samples were allowed to react with
120 μL Hisens auto RPR LTIA R1 (buffer) and 60 μL
Hisens auto RPR LTIA R2 (latex reagent containing car-
diolipin–lecithin–cholesterol, 1.0 mg/mL) in a CA-400
autoanalyzer (Furuno Electric Co, Nishinomiya, Japan).
The CA-400 photometric analyser was used for the auto-
mated procedure and analysis. Absorbance at 600 nm
was read after 5.3 and 10 s at room temperature, in
duplicate. Results of the HiSens auto RPR test equal to
or greater than 1.0 RPR unit (RU) were considered to
indicate reactive RPR. The upper detection limit was 20
RU.
Treponema pallidum particle agglutination
The Serodia TPPA assay (Fujirebio, Tokyo, Japan) is
based on agglutination of coloured gelatine particles
that have been sensitised (coated) with T. pallidum
(Nichols strain) antigen. For each specimen, a 100 μL
sample of diluent and 25 μL test specimen were mixed,
and then twofold serial dilutions were made with 25 μL
sample diluent. The sensitised particles were serially
mixed in the neighbouring wells with a plate mixer for
30 s. After 2 h of incubation at room temperature, the
result of the agglutination assay was read. The Serodia
TPPA assay results were interpreted using the agglutin-
ation patterns of positive and negative controls.
Statistical analysis
The percentage agreement (κ coefﬁcient) of the auto-
mated RPR test with the manual RPR card test was calcu-
lated. The overall sensitivity and speciﬁcity of each test
were calculated based on the TPPA results. κ values were
used to categorise results as very good (0.81–1.0), good
(0.61–0.8), moderate (0.41–0.6), fair (0.21–0.4) or poor
(0–0.2).9 The McNemar test was used to compare sero-
conversion rates between the automated RPR test and
the conventional manual RPR card test and was per-
formed using SPSS Statistics V.20. A p value <0.05 was
considered signiﬁcant.
Table 1 Comparison of non-treponemal RPR tests for
syphilis detection
HBI HiSens Auto
RPR test
Positive Negative
BD Macro-Vue RPR card Positive 32 22*
Negative 2† 56
Number of observed agreements: 88 (78.6% of the
observations)
κ=0.565
95% CI 0.422 to 0.709
*20 cases were positive and 2 cases (Nos 1 and 2 in table 2)
were negative in the TPPA test.
†The 2 cases (Nos 3 and 4 in table 2) were negative in the TPPA
test.
RPR, rapid plasma reagin; TPPA, Treponema pallidum particle
agglutination.
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RESULTS
A total of 112 serum samples from 59 patients with syph-
ilis (48±21 years old; male/female ratio 25:34 (0.7)) and
53 non-syphilitic controls (45±17 years old; male/female
ratio 27:26 (1)) after the treponemal test were collected
from November 2012 to April 2013 in a university hos-
pital in Korea.
The percentage agreement between the two RPR tests
was 78.6% (κ 0.565; 95% CI 0.422 to 0.709; table 1).
The strength of agreement between the automated RPR
test and the manual RPR card test was considered to be
‘moderate’ according to the κ value scale. Both
RPR-positive results (n=32) showed 96.9% (31/32)
TPPA-positive results, and both RPR-negative results
(n=56) showed 85.7% (48/56) TPPA-negative results.
There were 24 discrepant results (21.4%) between the
two RPR tests, including 22 negative HBI HiSens Auto
RPR LTIA test results that showed positive results on the
BD Macro-Vue RPR card test. Of these 22 discrepant
results, 20 were TPPA-positive and 2 were TPPA-negative,
while 2 cases were positive on the HBI HiSens Auto RPR
LTIA test but negative on the BD Macro-Vue RPR card
test. These two cases were negative on the TPPA test.
There were four results with discrepancies between both
the RPR tests and the TPPA assay, which was due to con-
ditions other than syphilis infection (table 2). The
strength of agreement between the automated RPR and
manual RPR tests was ‘fair’ (κ value 0.296, 59
TPPA-positive results; κ value 0.293, 53 TPPA-negative
results) according to the TPPA results (table 3).
The overall sensitivity and speciﬁcity of the HBI
HiSens Auto RPR LTIA test based on TPPA results were
52.5% (95% CI 39.1% to 65.7%) and 94.3% (95% CI
84.3% to 98.8%), respectively. The overall sensitivity and
speciﬁcity of the BD Macro-Vue RPR card test were
86.4% (95% CI 75% to 93.9%) and 94.3% (95% CI
84.3% to 98.8%), respectively (table 4). Automated RPR
gave a higher seroconversion rate after syphilis treatment
(43.5% (10/23)) than the conventional RPR card test
(4.3% (1/23)) (p=0.004) by the McNemar test.
A detailed comparison of the treated syphilis cases is
given in table 5.
DISCUSSION
The manual RPR test has been used for decades, but
recently an automated RPR test was launched and has
been used because of its convenience in clinical settings.
However, there was a need for thorough inspection and
a comparison of results of this new automated test with
the conventional manual RPR test in diagnostic
approaches. Treponemal test results will not change
even after treatment, and the patients live with positive
results for the rest of their lives regardless of treatment
or disease activity. Treponemal tests cannot discriminate
between past infections, active disease, treated patients
and non-treated patients.10 In contrast, non-treponemal
tests can discriminate between patients who have been
treated during the primary or secondary stage of the
disease. When the primary or secondary stage of a ﬁrst
T. pallidum infection is treated, the non-treponemal test
titre should show a twofold dilution decline after treat-
ment, usually within 6 months.7 Therefore, the non-
treponemal test is important for managing syphilitic
patients.
We compared an automated RPR test with a conven-
tional RPR card test on sera conﬁrmed by the TPPA test.
The TPPA test is known to be less subjective than the
Table 2 RPR results that were discrepant with the treponemal test for diagnosis of syphilis
Case
No
Age/
sex
RPR card
test
Automated RPR (RPR
unit) TPPA Clinical diagnosis
1 28/F 1+ Negative Negative Atopic dermatitis, antiphospholipid syndrome
2 50/F 1+ Negative Negative Bronchiectasis, secondary pulmonary
hypertension
3 22/M Negative 2.2 Negative Behcet’s disease
4 33/M Negative 1.1 Negative Chlamydia, Herpes penis
RPR, rapid plasma reagin; TPPA, Treponema pallidum particle agglutination.
Table 3 Comparison of non-treponemal RPR tests with TPPA test results
HBI HiSens Auto RPR HBI HiSens Auto RPR
TPPA positive (n=59) Positive Negative TPPA negative (n=53) Positive Negative
BD Macro-Vue RPR card Positive 31 20 BD Macro-Vue RPR card Positive 1 2
Negative 0 8 Negative 2 48
Number of observed agreements: 39 (66.1% of the
observations)
Number of observed agreements: 49 (92.5% of the
observations)
κ=0.296 κ=0.293
95% CI 0.118 to 0.474 95% CI −0.212 to 0.798
RPR, rapid plasma reagin; TPPA, Treponema pallidum particle agglutination.
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ﬂuorescent treponemal antibody absorption test and
easier to read than the microhaemagglutination assay
for antibodies to T. pallidum.11 The TPPA test has also
been suggested for use on cerebrospinal ﬂuid samples
for diagnosing neurosyphilis.12
In our study, the conventional BD Macro-Vue RPR
card test showed better sensitivity than the HBI HiSens
Auto RPR LTIA test in syphilis screening, although the
automated RPR test does have some advantages in the
clinical setting. For example, the automated RPR test
reduced the workload and overall test turnaround time.
It can also deal with greater test quantities in a given
time than the manual RPR card test and does not
require test experts. Furthermore, we observed that the
automated RPR test could be used as a monitoring
marker of treatment response, especially if treponemal
tests are used for ﬁrst-line screening of syphilis as a
reverse algorithm of syphilis testing. This reverse algo-
rithm for syphilis testing has been suggested and
adopted in many ﬁelds because it may be more sensitive
and effective than the traditional algorithm3 4 6 in a low-
prevalence area and can be automated. However, the
CDC still recommend ﬁrst screening for syphilis with a
non-treponemal test such as RPR.2
Our study found that the automated RPR test showed
earlier seroconversion than the conventional card RPR
test after syphilis treatment (p=0.004). If we adopt the
reverse algorithm, treponemal tests can be used ﬁrst to
screen sensitively, and then non-treponemal tests can be
used to accurately show negative changes in treated
cases. In this situation, we could use treponemal tests for
ﬁrst-line screening and non-treponemal tests for moni-
toring patients allowing us to observe seroconversion
more effectively after treatment.2 13 14 Unfortunately,
our study had a limited number of syphilitic patients
because of the low prevalence of syphilis in our country,
so the number of samples was small and could not been
classiﬁed according to syphilis stage. In fact, in some late
or latent syphilis cases, the results of the non-treponemal
test were hard to interpret after initial treatment in our
study (cases 8 and 9 in table 5). So, further well-
designed studies are needed to clarify the serological
responses of automated RPR tests after treatment and
according to the stage of syphilis infection.
In Korea, automated RPR tests have recently been
introduced in clinical laboratories, and evaluations com-
paring conventional RPR tests and VDRL tests have
been reported.8 15 However, the results were variable.
Onoe et al16 also suggested that, when the automated
serological testing method is used in clinical settings, the
same reagent should be consistently selected to evaluate
the changes in antibody titres, because the manual sero-
logical testing method for syphilis showed somewhat dif-
ferent results from the automated serological testing
methods. In this study, we noticed reasonably consistent
results between automated and manual RPR tests.
We found that the automated RPR test has greater
processing capability within a limited time and is effect-
ively applicable. Through the reverse syphilis screening
algorithm, we can increase the detection sensitivity of
syphilis screening by using the treponemal test for initial
screening, and then the automated RPR test after treat-
ment because of its rapid seroconversion, although the
sensitivity of the automated RPR test is lower than that
of the manual RPR test.
In conclusion, the automated RPR test showed an
overall lower sensitivity and similar speciﬁcity compared
with the conventional manual RPR card test. Therefore,
we consider that the automated RPR test is not appropri-
ate for use for initial screening for syphilis. However, it
produces an earlier seroconversion response in treated
cases than the conventional RPR card test. Applying the
reverse algorithm, the sensitive treponemal test can be
used as the ﬁrst-line screening test, and then the
Table 4 Performance characteristics of RPR tests for diagnosis of syphilis
Non-treponemal tests
TPPA
Positive Negative
HBI HiSens Auto RPR Positive 31 3
Negative 28 50
Sensitivity 52.5% (95% CI 39.1% to 65.7%)
Specificity 94.3% (95% CI 84.3% to 98.8%)
Positive predictive value 91.2% (95% CI 76.3% to 98%)
Negative predictive value 64.1% (95% CI 52.4% to 74.7%)
TPPA
Positive Negative
BD Macro-Vue RPR card Positive 51 3
Negative 8 50
Sensitivity 86.4% (95% CI 75% to 93.9%)
Specificity 94.3% (95% CI 84.3% to 98.8%)
Positive predictive value 94.4% (95% CI 84.6% to 98.8%)
Negative predictive value 86.2% (95% CI 74.6% to 93.8%)
RPR, rapid plasma reagin; TPPA, Treponema pallidum particle agglutination.
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Table 5 Comparison of manual and automated RPR test after initial syphilis treatment
Case
No Age Gender
Manual
RPR
Automated
RPR (RU) TPPA
Pretreatment
VDRL test value
Time after
initial treatment (days) Initial treatment Diagnosis
1 54 Male 2+ 0 1:5120 1:8 reactive 939 Penicillin G benzathine 1.2×106 IU Syphilis, latent
2 66 Male 0.5+ 0 1:640 1:1 weakly reactive 903 Penicillin G benzathine 1.2×106 IU Treated syphilis
3 17 Male 2+ 0 1:5120 1:4 reactive 222 Penicillin G benzathine 1.2×106 IU Syphilis, late, latent
4 62 Male 2+ 0 1:640 1:1 reactive 296 Penicillin G benzathine 1.2×106 IU Syphilis, other and unspecified
5 68 Male 1+ 0 1:320 1:1 weakly reactive 644 Penicillin G benzathine 1.2×106 IU Syphilis, late, latent
6 72 Male 1+ 0 1:640 1:1 weakly reactive 28 Penicillin G benzathine 1.2×106 IU Syphilis, late, unspecified
7 55 Female 0 0 1:1280 N/A 0 Penicillin G benzathine 1.2×106 IU Syphilis, latent
8 56 Female 1+ 0 1:5120 1:1 weakly reactive 7 Penicillin G benzathine 1.2×106 IU Syphilis, latent
9 65 Female 2+ 0 1:80 1:1 reactive 0 Penicillin G benzathine 1.2×106 IU Syphilis, late
10 33 Female 1+ 0 1:5120 1:8 reactive 936 Penicillin G benzathine 1.2×106 IU Syphilis, other and unspecified
11 28 Female 2+ 1 1:2560 1:1 reactive 1097 Penicillin G benzathine 1.2×106 IU Syphilis, late, latent
12 2 Male 2+ 1.1 1:5120 1:32 reactive 539 Penicillin G benzathine 1.2×106 IU Syphilis, congenital, latent
13 65 Male 3+ 1.3 1:640 1:1 reactive 273 Penicillin G Benzathine 1.2×106 IU Treated syphilis
14 70 Male 3+ 2.3 1:1280 1:1 reactive 188 Doxycycline 100 mg Syphilis, late, latent
15 48 Female 2+ 2.5 1:5120 1:1 weakly reactive 665 Penicillin G benzathine 1.2×106 IU Treated syphilis
16 36 Female 2+ 3.8 1:5120 1:2 reactive 810 Penicillin G benzathine 1.2×106 IU Syphilis, latent
17 74 Female 4+ 7.7 1:320 1:4 reactive 669 Penicillin G benzathine 1.2×106 IU Syphilis, late, latent
18 25 Female 4+ 8.1 1:5120 1:8 reactive 172 Penicillin G benzathine 1.2×106 IU Syphilis with pregnancy
19 64 Female 4+ 14.1 1:5120 1:8 reactive 0 Penicillin G benzathine 1.2×106 IU Chronic rhinitis
20 30 Male 4+ 20 1:2560 1:16 reactive 7 Penicillin G benzathine 1.2×106 IU Syphilis, late, unspecified
21 31 Female 2+ 20 1:5120 1:16 reactive 3 Penicillin G benzathine 1.2×106 IU Syphilis with pregnancy
22 51 Female 4+ 20.4 1:5120 1:8 reactive 417 Penicillin G benzathine 1.2×106 IU Syphilis, latent
23 37 Female 2+ 25.6 1:5120 1:16 reactive 0 Penicillin G benzathine 1.2×106 IU Treated syphilis
N/A, not applicable; RPR, rapid plasma reagin; RU, RPR unit; TPPA, Treponema pallidum particle agglutination; VDRL, Venereal Disease Research Laboratory.
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automated RPR test can be used as an adjunct to detect
earlier seroconversion in treated patients.
Further large-scale studies including patients cate-
gorised by syphilis stage are required to clarify the diag-
nostic efﬁciency of the automated RPR test.
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